PROtein S targeting to prevent BLEEDing

• Unité de recherche: INNOSUISSE
• Numéro de projet: 114.430 IP-LS
• Titre du projet anglais: PROtein S targeting to prevent BLEEDing

Mots-clé (Anglais)

Life sciences, Pharmaceuticals

Résumé des résultats (Abstract) (Anglais)

Hemophilia, impacting over 1.125 million people globally, is addressed by SLN140, a small interfering RNA therapy targeting protein S to prevent bleeding. Preclinical studies on its concept and safety aim for regulatory approval for a first-in-man study.